On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
A new systematic review and meta-analysis from Lavery, Wukich, Peters and team asks whether pre-biopsy antibiotics actually reduce bacterial culture yield in suspected diabetic foot osteomyelitis. Spoiler: maybe not.
We often view lower extremity amputation (LEA) as the culmination of a rapid clinical decline, but new data suggests the warning signs are flashing nearly a decade in advance. A large 10-year national study out of Denmark recently identified specific healthcare and sociodemographic markers that can predict amputation risk long before the situation becomes "limb... Continue Reading →
In the pursuit of better patient care, medical practitioners continually seek to refine treatment protocols. A recent review manuscript by seasoned podiatrists and infectious disease specialists, Warren Joseph, Mark Kosinski, and Lee C. Rogers, sheds new light on the management of Methicillin-resistant Staphylococcus aureus (MRSA) in diabetic foot infections (DFIs). This insightful work elucidates the... Continue Reading →
Potential Utility of Ultrasound-Enhanced Delivery of Antibiotics, Anti-Inflammatory Agents, and Nutraceuticals: A Mini Review This from our USC SALSA Team led by Karim Ead and Arjun Sharma. Abstract: Ultrasound technology has therapeutic properties that can be harnessed to enhance topical drug delivery in a process known as phonophoresis. The literature on this method of drug... Continue Reading →
Here is a popular table from our recent Infectious Diseases Society of America Diabetic Foot Infection Guidelines discussing suggested durations of therapy for soft tissue and bone infections.
